121 related articles for article (PubMed ID: 35697073)
1. Peroxiredoxin IV plays a critical role in cancer cell growth and radioresistance through the activation of the Akt/GSK3 signaling pathways.
Ding N; Jiang H; Thapa P; Hao Y; Alshahrani A; Allison D; Izumi T; Rangnekar VM; Liu X; Wei Q
J Biol Chem; 2022 Jul; 298(7):102123. PubMed ID: 35697073
[TBL] [Abstract][Full Text] [Related]
2. Essential Roles of Peroxiredoxin IV in Inflammation and Cancer.
Thapa P; Ding N; Hao Y; Alshahrani A; Jiang H; Wei Q
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235049
[TBL] [Abstract][Full Text] [Related]
3. Peroxiredoxin 4 ameliorates amyloid beta oligomer-mediated apoptosis by inhibiting ER-stress in HT-22 hippocampal neuron cells.
Kam MK; Lee DG; Kim B; Lee HS; Lee SR; Bae YC; Lee DS
Cell Biol Toxicol; 2019 Dec; 35(6):573-588. PubMed ID: 31147869
[TBL] [Abstract][Full Text] [Related]
4. Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells.
Skvortsova I; Skvortsov S; Stasyk T; Raju U; Popper BA; Schiestl B; von Guggenberg E; Neher A; Bonn GK; Huber LA; Lukas P
Proteomics; 2008 Nov; 8(21):4521-33. PubMed ID: 18821526
[TBL] [Abstract][Full Text] [Related]
5. DNA-PKcs plays a dominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression.
An J; Huang YC; Xu QZ; Zhou LJ; Shang ZF; Huang B; Wang Y; Liu XD; Wu DC; Zhou PK
BMC Mol Biol; 2010 Mar; 11():18. PubMed ID: 20205745
[TBL] [Abstract][Full Text] [Related]
6. Expression of peroxiredoxin 1 and 4 promotes human lung cancer malignancy.
Jiang H; Wu L; Mishra M; Chawsheen HA; Wei Q
Am J Cancer Res; 2014; 4(5):445-60. PubMed ID: 25232487
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of lncRNA MIR4435‑2HG and ST8SIA1 expression inhibits the proliferation, invasion and migration of prostate cancer cells
Xing P; Wang Y; Zhang L; Ma C; Lu J
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33846784
[TBL] [Abstract][Full Text] [Related]
8. SIRPB1 promotes prostate cancer cell proliferation via Akt activation.
Song Q; Qin S; Pascal LE; Zou C; Wang W; Tong H; Zhang J; Catalona WJ; Dhir R; Morrell M; Balasubramani GK; Lu Y; Wang Z
Prostate; 2020 Mar; 80(4):352-364. PubMed ID: 31905248
[TBL] [Abstract][Full Text] [Related]
9. Loss of Peroxiredoxin IV Protects Mice from Azoxymethane/Dextran Sulfate Sodium-Induced Colorectal Cancer Development.
Thapa P; Jiang H; Ding N; Hao Y; Alshahrani A; Lee EY; Fujii J; Wei Q
Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978925
[TBL] [Abstract][Full Text] [Related]
10. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q
Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507
[TBL] [Abstract][Full Text] [Related]
11. Peroxiredoxin 4 attenuates glutamate-induced neuronal cell death through inhibition of endoplasmic reticulum stress.
Kang JH; Kim MH; Lee HJ; Huh JW; Lee HS; Lee DS
Free Radic Res; 2020 Apr; 54(4):207-220. PubMed ID: 32241191
[TBL] [Abstract][Full Text] [Related]
12. Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance.
Chang L; Graham PH; Hao J; Ni J; Bucci J; Cozzi PJ; Kearsley JH; Li Y
Cell Death Dis; 2013 Oct; 4(10):e875. PubMed ID: 24157869
[TBL] [Abstract][Full Text] [Related]
13. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
14. Critical Role of the Sulfiredoxin-Peroxiredoxin IV Axis in Urethane-Induced Non-Small Cell Lung Cancer.
Hao Y; Jiang H; Thapa P; Ding N; Alshahrani A; Fujii J; Toledano MB; Wei Q
Antioxidants (Basel); 2023 Feb; 12(2):. PubMed ID: 36829926
[TBL] [Abstract][Full Text] [Related]
15. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
[TBL] [Abstract][Full Text] [Related]
16. Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells.
Wang L; Lin HK; Hu YC; Xie S; Yang L; Chang C
J Biol Chem; 2004 Jul; 279(31):32444-52. PubMed ID: 15178691
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
[TBL] [Abstract][Full Text] [Related]
18. PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling.
Conley-LaComb MK; Saliganan A; Kandagatla P; Chen YQ; Cher ML; Chinni SR
Mol Cancer; 2013 Jul; 12(1):85. PubMed ID: 23902739
[TBL] [Abstract][Full Text] [Related]
19. Characterization of 2-Cys peroxiredoxin 3 and 4 in common carp and the immune response against bacterial infection.
Yang YZ; Zhao Y; Yang L; Yu LP; Wang H; Ji XS
Comp Biochem Physiol B Biochem Mol Biol; 2018 Mar; 217():60-69. PubMed ID: 29277606
[TBL] [Abstract][Full Text] [Related]
20. Peroxiredoxin 4 knockout results in elevated spermatogenic cell death via oxidative stress.
Iuchi Y; Okada F; Tsunoda S; Kibe N; Shirasawa N; Ikawa M; Okabe M; Ikeda Y; Fujii J
Biochem J; 2009 Apr; 419(1):149-58. PubMed ID: 19105792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
